Scientists develop new natural killer cell strategy to target HIV

Scientists develop new natural killer cell strategy to target HIV

Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using natural killer (NK) cells to target and kill the HIV-positive cells that allow the virus to persist. Wistar scientists have labeled this new approach "NuKES": Natural Killer Enhancement Strategy.

A crash course in HIV

Join HIV researcher and Crick scientist Kate Bishop as she shares her insights into HIV and the work that scientists are doing to tackle it.

Scientists at The Wistar Institute’s HIV Cure and Viral Diseases Center Develop New Natural Killer Cell Strategy to Target HIV

PRESS RELEASE CONTACT: Darien Sutton 215-898-3988  |  dsutton@wistar.org PHILADELPHIA — (February 17th, 2025) — Researchers at The Wistar Institute’s HIV Cure and Viral Diseases Center have successfully identified a new approach using natural killer (NK) cells to target and kill the HIV-positive cells that allow the virus to persist. Wistar scientists have labeled this new approach “NuKES”: Natural Killer Enhancement Strategy. Led by Luis J.…